Charles River Laboratorie... (CRL)
NYSE: CRL
· Real-Time Price · USD
156.64
0.84 (0.54%)
At close: Aug 15, 2025, 3:59 PM
156.68
0.03%
After-hours: Aug 15, 2025, 05:29 PM EDT
Charles River Laboratories International Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 28, 2025 | Mar 29, 2025 | Dec 28, 2024 | Sep 28, 2024 | Jun 29, 2024 | Mar 30, 2024 | Dec 30, 2023 | Sep 30, 2023 | Jul 1, 2023 | Apr 1, 2023 | Dec 31, 2022 | Sep 24, 2022 | Jun 25, 2022 | Mar 26, 2022 | Dec 25, 2021 | Sep 25, 2021 | Jun 26, 2021 | Mar 27, 2021 |
Revenue | 4.03B | 4.02B | 4.05B | 4.06B | 4.08B | 4.11B | 4.13B | 4.22B | 4.18B | 4.09B | 3.98B | 3.78B | 3.69B | 3.63B | 3.54B | 3.43B | 3.27B | 3.04B |
Cost of Revenue | 2.05B | 2.72B | 2.72B | 2.65B | 2.65B | 2.64B | 2.63B | 2.68B | 2.63B | 2.63B | 2.55B | 2.41B | 2.35B | 2.27B | 2.21B | 2.14B | 2.03B | 1.91B |
Gross Profit | 951M | 1.3B | 1.33B | 1.41B | 1.42B | 1.47B | 1.5B | 1.54B | 1.55B | 1.47B | 1.42B | 1.37B | 1.34B | 1.36B | 1.33B | 1.29B | 1.24B | 1.13B |
Operating Income | 124.52M | 176.04M | 227.35M | 527.96M | 562.05M | 575.35M | 617.26M | 764.04M | 763.51M | 787.34M | 768.23M | 661.34M | 666.16M | 614.94M | 589.86M | 545.98M | 522.93M | 462.15M |
Interest Income | 5.86M | 7.78M | 8.57M | 8.33M | 8.18M | 6.59M | 5.2M | 3.95M | 2.7M | 1.46M | 780K | 746K | 761K | 744K | 652K | 406K | 448K | 553K |
Pretax Income | -18.15M | 30.08M | 93.11M | 518.61M | 540.24M | 549.25M | 581.28M | 617.5M | 627.73M | 643.18M | 622.99M | 541.71M | 541.87M | 525.25M | 480.71M | 489.5M | 501.5M | 457.96M |
Net Income | -69.22M | -31.56M | 10.3M | 413.08M | 431.79M | 438.82M | 474.62M | 474.95M | 484.03M | 496.33M | 486.23M | 436.39M | 443.35M | 422.47M | 390.98M | 396.6M | 396.08M | 375.06M |
Selling & General & Admin | 764.27M | 742.51M | 751M | 752.44M | 729.33M | 759.3M | 747.86M | 750.35M | 757.96M | 687.98M | 663.17M | 607.64M | 572.5M | 614.22M | 619.92M | 618.84M | 598.56M | 554.77M |
Research & Development | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Expenses | 353.89M | 386.16M | 353.47M | 131.27M | 133.09M | 135.1M | 137.44M | 138.85M | 88.01M | 53.73M | 56.83M | 23.46M | 23.86M | 29.83M | -35.89M | 38.62M | 76.04M | 96.34M |
Operating Expenses | 1.12B | 1.13B | 1.1B | 883.71M | 862.43M | 894.4M | 885.29M | 889.21M | 898.12M | 793.86M | 772.14M | 711.37M | 673.55M | 748.24M | 744.78M | 741.51M | 716.61M | 667.61M |
Interest Expense | 56.44M | 119.17M | 126.29M | 131.6M | 135.06M | 137.33M | 136.71M | 137.94M | 115.58M | 84.24M | 59.29M | 36.06M | 41.14M | 53.63M | 73.91M | 95.51M | 97.92M | 101.08M |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 2.97B | 3.85B | 3.82B | 3.53B | 3.52B | 3.54B | 3.51B | 3.57B | 3.53B | 3.42B | 3.32B | 3.12B | 3.02B | 3.01B | 2.95B | 2.88B | 2.75B | 2.58B |
Income Tax Expense | 46.73M | 53.39M | 67.82M | 90.62M | 94.53M | 98.36M | 100.91M | 136.97M | 137.62M | 141.85M | 130.38M | 98.38M | 91M | 95.13M | 81.87M | 86.3M | 100.85M | 79.55M |
Shares Outstanding (Basic) | 49.15M | 50.68M | 51.14M | 51.39M | 51.55M | 51.44M | 51.31M | 51.28M | 51.22M | 51.31M | 50.91M | 50.87M | 50.82M | 50.64M | 50.47M | 50.42M | 50.3M | 49.98M |
Shares Outstanding (Diluted) | 49.32M | 50.85M | 51.14M | 51.58M | 51.85M | 51.84M | 51.62M | 51.61M | 51.47M | 51.43M | 51.38M | 51.28M | 51.28M | 51.33M | 51.55M | 51.56M | 51.33M | 51.08M |
EPS (Basic) | -1.32 | -0.63 | 0.29 | 8.16 | 8.52 | 8.66 | 9.25 | 9.28 | 9.48 | 9.74 | 9.57 | 8.62 | 8.77 | 8.38 | 7.77 | 7.92 | 7.94 | 7.54 |
EPS (Diluted) | -1.33 | -0.65 | 0.26 | 8.10 | 8.46 | 8.61 | 9.21 | 9.24 | 9.43 | 9.67 | 9.47 | 8.49 | 8.62 | 8.21 | 7.60 | 7.74 | 7.76 | 7.38 |
EBITDA | 407.63M | 546M | 581.14M | 990.36M | 1.01B | 1.01B | 1.03B | 1.07B | 1.07B | 1.07B | 1.01B | 910.44M | 897.4M | 869.79M | 841.17M | 839.19M | 839.46M | 782.82M |
EBIT | -3.17M | 149.25M | 219.4M | 650.21M | 675.3M | 686.59M | 717.99M | 755.44M | 743.31M | 727.42M | 682.28M | 587.52M | 592.76M | 588.63M | 564.37M | 585.01M | 599.42M | 559.04M |
Depreciation & Amortization | 310.67M | 396.75M | 361.74M | 340.15M | 330.82M | 322.41M | 314.12M | 311.15M | 306.89M | 305.64M | 303.87M | 294.43M | 288.51M | 280.19M | 266.4M | 259.18M | 250.07M | 239.17M |